Earnings Reports
Filter News
Found 71,744 articles
-
There’s plenty of money on the move as venture capital firms and investors look to the future of biotech. Read on for today’s top Series A rounds.
-
It’s been a bumpy ride for Biogen as news swirls around its overall Alzheimer’s program… but not for its competitors with investigational therapies for that disease.
-
uniQure has acquired Corlieve with upfront cash of approx. $55 million and will center on the latter's lead program, AMT-260, an advanced treatment for TLE.
-
BiondVax Announces First Quarter 2021 Financial Results and Provides Business Update
6/23/2021
BiondVax Pharmaceuticals Ltd., a biopharmaceutical company focused on developing, manufacturing and ultimately commercializing products for the prevention and treatment of infectious diseases and related illnesses, published its first quarter financial results for the quarter ended March 31, 2021.
-
Patterson Companies Reports Fiscal 2021 Fourth-Quarter and Year End Operating Results
6/23/2021
Fourth-quarter reported net sales increased 21.4 percent year-over-year to $1.56 billion, and internal sales increased 23.5 percent. Fourth-quarter GAAP earnings of $0.30 per diluted share and adjusted earnings per share of $0.38 per diluted share.
-
The business combination agreement will advance SAB’s proprietary platform to develop antibody therapies for immune system disorders and other diseases.
-
As part of the announcement, TRexBio indicated that Johnston Erwin had been appointed CEO and Ovid Trifan would be the company’s CMO.
-
Halozyme revealed that ViiV will pay $40 million upfront for the exclusive license to four small and large molecule targets and then pay the remaining $175 million in milestones.
-
Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2021
6/22/2021
Cyanotech Corporation announced financial results for the fourth quarter and fiscal year 2021, ended March 31, 2021.
-
Global Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2021 Financial Results
6/22/2021
Global Cord Blood Corporation, China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, announced that it plans to release unaudited financial results for the fourth quarter and full year fiscal 2021 on Monday, June 28, 2021, after the U.S. market close.
-
Acasti Pharma Provides Fiscal 2021 Year-End Business Update
6/22/2021
Acasti Pharma Inc. announced its operating and financial results for the fiscal year ended March 31, 2021, and provided an update on its plans to acquire Grace Therapeutics and the ongoing strategic process for CaPre.
-
Affimed to Report First Quarter 2021 Financial Results & Corporate Update July 1, 2021
6/22/2021
Affimed N.V., a clinical stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced that it will release first quarter 2021 results on Thursday, July 1, 2021, and host a conference call at 8:30 a.m. EDT to discuss financial results and recent corporate developments.
-
Avid Bioservices to Report Financial Results For Quarter and Fiscal Year Ended April 30, 2021 After Market Close on June 29, 2021
6/22/2021
Avid Bioservices, Inc. today announced that it will report financial results for the quarter and fiscal year (FY) ended April 30, 2021 on June 29, 2021 after market close and will host a conference call on June 29, 2021.
-
Anebulo Pharmaceuticals Reports Recent Business Highlights and Announces Third Quarter Fiscal Year 2021 Financial Results
6/21/2021
Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB) (“Anebulo” or the “Company”), a clinical-stage biotechnology company developing novel solutions for people suffering from cannabinoid intoxication and substance addiction, today reported recent business highlights and announced financial results for the fiscal year 2021 third quarter, ended March 31, 2021.
-
Aethlon Medical to Release Fourth Quarter Financial Results and Host Conference Call on June 24, 2021
6/21/2021
Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced that it will issue financial results for its fourth quarter fiscal year 2021, ended March 31, 2021, at 4:15 p.m. ET on Thursday, June 24, 2021
-
Taro Annual Report on Form 20-F Available For Fiscal Year Ended March 31, 2021
6/18/2021
Taro Pharmaceutical Industries Ltd. announced that its Annual Report on Form 20-F for the fiscal year ended March 31, 2021, filed with the Securities and Exchange Commission (the “SEC”), is available within the Investor Relations section of Taro’s website at www.taro.com .
-
Jazz Pharmaceuticals Updates 2021 Financial Guidance to Include Recently Acquired GW Pharmaceuticals plc
6/17/2021
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today updated its full year 2021 financial guidance to incorporate the GW Pharmaceuticals (GW) business.
-
AbbVie Declares Quarterly Dividend - June 17, 2021
6/17/2021
The board of directors of AbbVie Inc. declared a quarterly cash dividend of $1.30 per share.
-
IBEX Reports Results for the Third Quarter and the Nine Months Ended April 30, 2021
6/17/2021
IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) today reported its financial results for the nine months ended April 30, 2021.
-
BeyondSpring Announces First Quarter 2021 Financial Results and Provides a Corporate Update
6/16/2021
BeyondSpring today announced its financial results for the first quarter ended March 31, 2021 and provided an update on recent corporate events.